Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors.
Yimin Qian, Mushtaq Ahmad, Shaoqing Chen, Paul Gillespie, Nam Le, Frank Mennona, Steven Mischke, Sung-Sau So, Hong Wang, Charles Burghardt, Shahid Tannu, Karin Conde-Knape, Jarema Kochan, David Bolin
Index: Bioorg. Med. Chem. Lett. 21 , 6264-6269, (2011)
Full Text: HTML
Abstract
Through high throughput screening and subsequent hit identification and optimization, we synthesized a series of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as the first reported potent and reversible GFAT inhibitors. SAR studies of this class of compounds indicated significant impact on GFAT inhibition potency by substitutions on the A-ring and C-ring. The ketone group was found to be necessary for high potency. Compound 28 (RO0509347) demonstrated potent GFAT inhibition (IC(50)=1μM) with a desirable pharmacokinetic profile in rats, and showed significant efficacy in reducing the glucose excursion in an OGTT test in ob/ob mice.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
Glucosamine-6-phosphate synthase--the multi-facets enzyme.
2002-06-03
[Biochim. Biophys. Acta 1597 , 173-192, (2002)]
Highlights of glucosamine-6P synthase catalysis.
2008-06-15
[Arch. Biochem. Biophys. 474 , 302-317, (2008)]
2002-04-26
[J. Biol. Chem. 277 , 14764-14770, (2002)]
2012-02-01
[Plant Physiol. 158 , 917-929, (2012)]
2013-04-01
[Planta 237(4) , 943-54, (2013)]